Key Clinical Summary: Living With AFib and the Clinical Realities of Anticoagulation

This is a micro-learning module summary of Tom Buffalano’s session which you can find here. Before participating, please read our CME and disclosure information which can be found here.

Acknowledgment: This activity is supported by an educational grant from Johnson & Johnson and Bristol Myers Squibb. This online education program is intended exclusively for healthcare professionals in the United States.

Introduction

Atrial fibrillation imposes a daily cognitive, emotional, and practical burden that goes far beyond arrhythmia symptoms. Understanding the lived experience of AF helps clinicians strengthen shared decision-making, tailor anticoagulation strategies, and address the anxiety patients carry around stroke prevention, bleeding risks, lifestyle limitations, and medication access. This summary outlines key patient-centred considerations relevant to guideline-informed AF management.

Case Context: Tom

Tom is an endurance cyclist and runner with a strong family history of AF (two siblings and mother). He first noted irregular heartbeats during exercise and stressful situations, followed by a sustained nighttime episode that led to emergency evaluation and AF diagnosis. He later developed both AF and atrial flutter, with recurrent symptomatic episodes that disrupted sleep, exercise, and daily functioning.

His profile reflects common patterns in AF:

• Genetic predisposition
• Symptomatic episodes linked to exertion and stress
• Progressive frequency of arrhythmia leading to persistent AF

Diagnosis and Stroke Risk: Patient Perception

Learning that AF increases stroke risk is a turning point for many patients. Tom describes:

• Persistent awareness of stroke as a daily worry.
• A strong need to understand his condition, which improved engagement but also heightened anxiety.
• Family experience with anticoagulants reinforcing the seriousness of long-term prevention.

This underscores the role of clear communication about stroke prevention, delivered in a way that acknowledges fear while reinforcing control through evidence-based therapy.

Daily Life Impact: Functional and Emotional Load

AF reshapes routines, identity, and health behavior. Key burdens reported include:

• Exercise and Activity Modification: Endurance exercise triggered episodes, forcing significant lifestyle adjustments, particularly challenging for individuals whose identity is tied to athletic activity.
• Medication Regimen and Monitoring: Daily anticoagulation requires consistent routines: taking the medication with food, at the same time each day, and keeping up with regular checkups and blood work. This adds a structured, ongoing treatment schedule to everyday life.
• Continuous Self-Management: Patients learn to pay attention to symptoms, exertion levels, and situations that might provoke AF. This ongoing monitoring becomes part of how they plan their days.
• Dietary and Lifestyle Adjustments: Patients frequently adopt strict routines around alcohol, processed foods, blood pressure control, and weight management to minimise AF triggers and support cardiovascular health.
• Impact on Daily Confidence and Routine: Unpredictable episodes disrupt sleep and create uncertainty, particularly when symptoms occur at night or during important activities. Patients may adjust plans or routines to feel more prepared should an episode arise.

Anticoagulation: The Real-World Balance Patients Navigate

Anticoagulants lower stroke risk but introduce bleeding concerns that affect daily choices. Tom reports several recurring challenges:

• Minor but Frequent Bleeding
• Shaving-related cuts
• Spontaneous nosebleeds
• The need to carry absorbent agents (e.g., “bleed stop” products)
• Planning Around Bleeding Risk
• Shaving the night before professional commitments
• Evaluating daily tasks by their likelihood of injury
• Avoiding outdoor cycling due to fear of internal bleeding after falls
• Anxiety about car accidents or routine bumps/bruises

For many patients, anticoagulation becomes a full-time mental job, influencing clothing, travel, activities, and social plans.

Therapeutic Innovation: What Reduced Bleeding Risk Would Mean Clinically

A therapy capable of preventing clots while reducing bleeding risk would have profound quality-of-life implications. Patients consistently express potential benefits such as:

• Reduced daily anxiety about injuries
• Increased willingness to exercise outdoors
• Freedom from planning around shaving, nosebleeds, or small cuts
• Greater social participation and physical confidence

Clinically, this reinforces why emerging therapies targeting safer thrombo-protection may address unmet needs even among patients well-maintained on current agents.

Adherence Barriers: Cost, Access, and Healthcare Navigation

Adherence depends not only on motivation but also socioeconomic stability. Key barriers:

• Cost and Insurance Instability: Loss of employer-sponsored insurance makes anticoagulants financially prohibitive and freelancers or workers in unstable employment face inconsistent access to affordable therapy.
• Limited System Navigation Support: Patients often feel alone in managing coverage, replacement options, and refills, especially when healthcare systems are fragmented.

This highlights the necessity of screening for cost or access barriers, providing guidance on insurance pathways and discussing coverage changes proactively

What Patients Need From Their Clinical Team

Patients describe AF care as a partnership that should be proactive, continuous, and emotionally supportive. Key expectations include:

• Consistent guidance from cardiology teams, especially after acute episodes.
• Support for emotional and mental health, acknowledging that AF can create anxiety and trauma-like responses.
• Team-based continuity, where medical community and family support align.

Conclusion

Living with atrial fibrillation involves far more than rhythm disturbances. Patients must constantly balance stroke prevention against the worry and inconvenience of bleeding, adapt their lifestyle, and navigate emotional stress and treatment costs. Evidence-based care requires not only selecting the right anticoagulant but also recognising the lived burden that shapes adherence, patient priorities, and quality of life. Emerging therapies that offer safer thrombo-protection may meaningfully reduce daily anxiety, expand activity options, and improve long-term wellbeing.

A patient-centred partnership, grounded in empathy, clear risk communication, and shared decision-making, remains essential for delivering guideline-aligned AF care.

Content is accurate as of the date of release on 6 January 2026.